Skip to main content

Table 1 Patient characteristics at baseline

From: Improvement of quality of life through glycemic control by liraglutide, a GLP-1 analog, in insulin-naive patients with type 2 diabetes mellitus: the PAGE1 study

Characteristics

Value

Age, years

59.4 ± 12.3

Height, cm

162.6 ± 9.6

Duration of diabetes, months

115.0 ± 88.8

Men

119 (58.3)

Macrovascular complications of diabetes

36 (17.7)

Arteriosclerosis obliterans

8 (3.9)

Coronary heart disease

19 (9.3)

Stroke

15 (7.3)

Diabetic microangiopathy

106 (52.0)

Diabetic retinopathy

49 (24.0)

Diabetic neuropathy

47 (23.0)

Diabetic nephropathy

83 (40.6)

Sulfonylurea before using GLP-1

123 (60.3)

  1. n = 204 except for height (n = 203) and duration of diabetes (n = 197) because of missing data. Data are shown as the mean ± SD or the number of patients (%)